Dialectic Therapeutics
Dallas
About Dialectic Therapeutics
Dialectic Therapeutics (DT) is a pre-clinical biotechnology company dedicated to the development of unique, impactful anti-cancer drugs that effectively treat patients with few to no other options. The company's drugs selectively induce cancer cells to degrade B-cell lymphoma and stimulate the cells to commit suicide or become susceptible to chemotherapy, enabling patients to have increased disease-free survival. Dialectic Therapeutics was founded in 2018 and is located in Dallas, Texas.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $19.9M
- Last round: Grant (Aug 2021)
- Website: dtsciences.com
- Phone: 972.888.8179
Industries & Categories
Biotechnology, Life Science, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/dialectic-therapeutics-70473 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.